Ads
related to: crispr-cas9
Search results
Gene editing's next big targets
Axios· 5 hours agoThe big picture: The potential of CRISPR gene-editing technology was realized six months ago, when the Food and Drug Administration approved the first...
Here’s what a Nobel Prize-winning scientist wants you to know about the Covid-19 vaccines and the...
CNN via Yahoo News· 2 days agoIn his new book “The Catalyst,” Thomas R. Cech talks about the Covid-19 vaccines, what RNA means for...
Pairwise Grants License to Proprietary Fulcrum™ Platform Tools to Solis Agrosciences for Custom...
Benzinga· 15 hours agoPairwise, a company pioneering the application of CRISPR technology in food and agriculture, has granted a full technology license to its proprietary Fulcrum™ Platform to ...
AI plus gene editing promises to shift biotech into high gear
The Conversation via Yahoo News· 15 hours agoAI has learned the ins and outs of proteins. Gene editing gives scientists control of life’s...
Cathie Wood's ARK buys PagerDuty, CRISPR, sells Zoom stock By Investing.com
Investing.com· 6 days agoCathie Wood's ARK buys PagerDuty, CRISPR, sells Zoom stock
US scientists create world’s first seedless blackberry using CRISPR
Interesting Engineering· 2 days agoThis has led them to develop the world’s first seedless blackberry. Short for Clustered Regularly...
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You?
Motley Fool via Yahoo Finance· 3 days agoCathie Wood is buying the dip on two biotechs in particular, so for her, the answer to that question...
Top Stock Reports for NVIDIA, Tesla & Linde
Zacks via Yahoo Finance· 9 hours agoToday's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Tesla, Inc. (TSLA) and Linde plc (LIN), as...
Repare (RPTX) Up 14% as Ovarian Cancer Combo Gets Fast Track Tag
Zacks via Yahoo Finance· 13 hours agoRepare (RPTX) rises 14% as the FDA grants Fast Track designation to its investigational...
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The Motley Fool via AOL· 12 hours agoHowever, the gene-editing stock is moving higher this week. Intellia investors got a boost this week...
Ad
related to: crispr-cas9